We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Trade smarter, not harder: Unleash your inner pro with our toolkit and live discussions.
The current LUNG market cap is 297.51M. The company's latest EPS is USD -1.5788 and P/E is -4.89.
| Quarter End | Sep 2022 | Dec 2022 | Mar 2023 | Jun 2023 | Sep 2023 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Revenue | 13.5M | 15.43M | 14.54M | 17.19M | 17.67M |
| Operating Income | -13.93M | -14.63M | -16.4M | -16.44M | -15.18M |
| Net Income | -14.17M | -14.28M | -15.86M | -16.2M | -14.9M |
| Year End December 30 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Revenue | 32.6M | 32.73M | 48.42M | 53.66M | 68.68M |
| Operating Income | -17.84M | -32.33M | -47.3M | -58.64M | -61.94M |
| Net Income | -20.7M | -32.23M | -48.66M | -58.92M | -60.84M |
| Quarter End | Sep 2022 | Dec 2022 | Mar 2023 | Jun 2023 | Sep 2023 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Assets | 202.2M | 193.68M | 201.27M | 193.11M | 185.02M |
| Total Liabilities | 38.72M | 39.67M | 57.34M | 59.16M | 59.27M |
| Total Equity | 163.48M | 154.01M | 143.93M | 133.95M | 125.74M |
| Year End December 30 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Assets | 53.53M | 263.71M | 235.17M | 193.68M | 177.78M |
| Total Liabilities | 35.57M | 37.57M | 41.93M | 39.67M | 59.47M |
| Total Equity | -187.38M | 226.13M | 193.24M | 154.01M | 118.32M |
| Quarter End | Sep 2022 | Dec 2022 | Mar 2023 | Jun 2023 | Sep 2023 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Operating | -35.28M | -45.08M | -12.64M | -20.54M | -29.16M |
| Investing | -3.5M | -4.23M | 574k | -239k | 748k |
| Financing | 2.35M | 2.42M | 20.72M | 20.81M | 21.38M |
| Year End December 30 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Operating | -20.77M | -30.63M | -41.39M | -45.08M | -37.61M |
| Investing | -14.23M | 12.69M | -46.26M | -4.23M | -2.01M |
| Financing | 45.62M | 234.83M | 4.46M | 2.42M | 21.4M |
| Market Cap | 297.51M |
| Price to Earnings Ratio | -4.89 |
| Price to Sales Ratio | 4.33 |
| Price to Cash Ratio | 3.56 |
| Price to Book Ratio | 2.51 |
| Dividend Yield | - |
| Shares Outstanding | 38.54M |
| Average Volume (1 week) | 539.81k |
| Average Volume (1 Month) | 516.57k |
| 52 Week Change | -36.72% |
| 52 Week High | 14.92 |
| 52 Week Low | 7.11 |
| Spread (Intraday) | 0.37 (3.75%) |
| Company Name | Pulmonx Corporation |
| Address |
corporation trust center wilmington, delaware 19801 |
| Website | https://www.pulmonx.com |
| Industry | surgical,med instr,apparatus (3841) |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
Hot Features
Premium
